Deep learning algorithms help battle against brain disorders

Scientists are treating brain disorders with AI and microelectronics in work which may also help with chronic pain, depression and dementia in the future

Researchers are using artificial intelligence, microelectronics, and neural implants to help treat brain disorders such as Parkinson’s disease and epilepsy by directly modulating abnormal activities.

“Neurons talk to each other in part via electrical signals, and a therapeutic neural implant produces electrical stimulation – like a pacemaker for the brain,” says University of Toronto’s Xilin Liu, an Assistant Professor in the Faculty of Applied Science & Engineering. “In cases of tremors or seizures, the stimulation attempts to restore the neurons to a normal condition.

“It’s as if the stimulus turns the neural networks off and on – almost like restarting a computer, though it’s definitely not that simple. Scientists don’t fully understand how it works yet.”

Liu’s team integrates neural implants into miniature silicon chips via the same process for fabricating chips used in today’s computers and smartphones. This technology allows them to reduce the device’s physical dimensions and power consumption, thus minimising the risks associated with the implant’s initial surgical procedure and long-term use.

“We’ve developed many new microelectronic design techniques, such as high precision electrical stimulation with charge balancing,” says Liu. “We try to come at the problem from many different angles.”

Liu is part of the neurotechnology centre CRANIA, a collaboration between the University of Toronto and the University Health Network, that brings together electrical and computer engineers alongside neuroscientists, data and material scientists and clinicians. Together, they research ways to improve brain health and chart alternative treatment paths, especially for those who don’t respond well to current medications.

Deep learning algorithms extra deep-level information

In a recent project, Liu and his team sought to leverage the power of AI to maximise the implants’ clinical efficacy and minimise the adverse effects of excessive stimulation.

The team turned to deep learning (DL) AI algorithms to extract deep-level information. These models proved to be especially powerful at identifying hidden biomarkers often neglected in conventional approaches and they outperformed conventional algorithms when detecting the optimal timing, say researchers.

“Most existing implants produce electrical stimulation at a constant rate, regardless of the patient’s condition,” says Liu. “With DL, we can activate the neural implants at the optimal time and only when necessary.”

The high computational cost of deep learning models makes it a challenge to integrate, especially considering that it’s essential that all processing runs locally in the implants.

“The cloud would provide more processing power, but you can’t have an implant fail because it loses telecommunication service – when a patient goes into an elevator or aeroplane, for example,” says Liu.

To reduce this computational cost, Liu and his team developed techniques for training and optimising the models for each patient’s condition. A recent case study showed that the detection of epileptic seizures by deep learning in low-power neural implants was comparable to state-of-the-art algorithms that run in high-performance computers. This work was published in 2021 in the Journal of Neural Engineering.

Liu says that his team’s technology can be used in a broad range of clinical applications beyond epilepsy, noting that up to one billion people worldwide suffer from various brain disorders. Future targets include chronic pain, depression and dementia. Liu is already contemplating how neuromodulation therapies may help people with Alzheimer’s disease.

“Impaired sleep has been associated with Alzheimer’s, and many people suffer from different levels of sleep disorders,” says Liu. “We are investigating closed-loop neuromodulation techniques to improve sleep quality by reinforcing or inhibiting certain brain rhythms. The brain is pretty amazing.”


Featured Articles

IBM & Boehringer Ingelheim partner to advance health GenAI

Both organisations are collaborating to advance generative AI & foundation models for therapeutic antibody development, aiming to improve patient outcomes

ChatGPT one year on: adoption, transformation, regulation

OpenAI’s ChatGPT turns one year old today and, with much global conversation taking place, businesses continue to seek the benefits of generative AI

IBM continues to address climate change via geospatial AI

Ahead of COP28, IBM announce collaborations with NASA & Mohamed Bin Zayed University of AI to expand upon IBM geospatial AI tech and monitor climate change

Agility Robotics: Digit, Amazon and workplace efficiencies


Unlocking the possibilities of AI with Mondee’s Kymber Lowe


ChatGPT's first birthday: A year in review

Machine Learning